Suchergebnisse - "Rosmorduc, O"

PubPharm (74)

1

Early tumor shrinkage and response assessment according to mRECIST predict overall survival in hepatocellular carcinoma patients under sorafenib

enthalten in: Cancer imaging : the official publication of the International Cancer Imaging Society | 2022

von Öcal, O. | Schinner, R. | Schütte, K. | +70

2

Temporal trends, clinical patterns and outcomes of NAFLD-related HCC in patients undergoing liver resection over a 20-year period

enthalten in: Alimentary pharmacology & therapeutics | 2017

von Pais, R. | Fartoux, L. | Goumard, C. | +4

CommentIn: Aliment Pharmacol Ther. 2018 Feb;47(3):437-438. - PMID 29314126

3

Temporal trends, clinical patterns and outcomes of NAFLD‐related HCC in patients undergoing liver resection over a 20‐year period

enthalten in: Alimentary pharmacology & therapeutics | 2017

von Pais, R. | Fartoux, L. | Goumard, C. | +4

4

Non-AIDS-related malignancies : expert consensus review and practical applications from the multidisciplinary CANCERVIH Working Group

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2016

von Spano, J. | Poizot-Martin, I. | Costagliola, D. | +14

5

Non-AIDS-related malignancies: expert consensus review and practical applications from the multidisciplinary CANCERVIH Working Group

enthalten in: Annals of oncology | 2016

von Spano, J. | Poizot-Martin, I. | Costagliola, D. | +14

6

Biomarker Analyses of Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib with or without Erlotinib in the SEARCH Trial

enthalten in: Clinical cancer research | 2016

von Zhu, A. | Kang, Y. | Rosmorduc, O. | +8

7

Efficacy, safety, and health-related quality of life (HRQoL) of regorafenib in patients with hepatocellular carcinoma (HCC) progressing on sorafenib: Results of the international, double-blind phase 3 RESORCE trial

enthalten in: Annals of oncology | 2016

von Bruix, J. | Merle, P. | Granito, A. | +17

8

Safety and toxicity of radioembolization plus Sorafenib in advanced hepatocellular carcinoma : analysis of the European multicentre trial SORAMIC

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2015

von Ricke, J. | Bulla, K. | Kolligs, F. | +49

9

18F-fluorocholine may be taken-up by brown adipose tissue

enthalten in: Nuklearmedizin. Nuclear medicine | 2013

von Balogova, S. | Michaud, L. | Vereb, M. | +7

10

Relationship between hepatocellular carcinoma, metabolic syndrome and non-alcoholic fatty liver disease: Which clinical arguments?

enthalten in: Annales d'endocrinologie | 2013

von Rosmorduc, O.

1
2
3
4
5
6
7
8
Nächster »
[8]